THERMO RECENT VIDEOS AND WEBINARS
CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic
As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.
Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview
From lab to production scale: a researcher's firsthand account of what bioreactor scaling and high-density perfusion really demand in practice.
How MacroGenics Increased mAb Titers By Up To 80% In Scale-Up
Learn how a structured, scalable approach to process development can help improve productivity, maintain product quality, and support a smoother transition to manufacturing.
Boost CHO Cell Protein Production By Up To 146% With Efficient-Pro™ Feed Solutions
Up to 146% higher protein titers in CHO-K1 culture. See how advanced feed technology and animal–origin–free formulations are redefining what consistent protein production looks like.
Driven By Performance: Empowering Biotech Innovation From Lab To Life
See how the right biotech products, workflows, and technical expertise help teams accelerate development and bring life-changing therapies from lab to commercial reality.
Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter
Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.
DynaDrive S.U.B. Video Series
Explore DynaDrive Single-Use Bioreactors through expert videos covering reactor design, mixing performance, sparge technology, and scalable workflows from bench-scale to commercial production.
Digital Design Meets Proven Performance: The Future Of Single-Use Assemblies
Single-use assembly design is evolving fast. Learn how scalable platforms, digital automation tools, and global supply networks are converging to support sustainable biopharma manufacturing at scale.
DynaDrive Single-Use Bioreactors Drilled-Hole Sparge Technology
Uniform bubble size and consistent mass transfer across scales through drilled-hole sparge technology improves oxygen delivery and CO2 stripping in demanding cell culture processes.
DynaDrive Single-Use Bioreactors - One Reactor, Many Volumes
Single-use bioreactors with turndown ratios up to 20:1 enable facilities to operate across wide volume ranges within the same vessel, streamlining seed trains and reducing capital requirements for multi-product operations.
Scale With Confidence From Bench To Commercial Production
Consistent vessel design, sparging, and bag materials across 1L to 5,000L volumes enable predictable bioreactor scale-up from development through commercial manufacturing.
Why Is The Bioreactor Square? The Geometry Behind Exceptional Mixing
Cuboid bioreactor design eliminates vortexing through natural baffling, delivering homogeneous mixing and consistent nutrient distribution for high cell density upstream processes.
Aegis Film For DynaDrive Single-Use Bioreactors
PFAS-free bioreactor film technology provides proven biocompatibility and strength across workflows while simplifying validation and reducing material variability for compliant operations.
Applying AI And Rapid Prototyping To Media And Process Development
Hear from industry experts on how teams can integrate manufacturability considerations earlier through rapid prototyping, data-driven media development, and predictive modeling.
Five Reasons To Choose Single-Use Bioreactors
Explore five key advantages of single-use bioreactors, including scalable design, homogeneous mixing, broad chemical compatibility, and streamlined seed train processes for bioproduction success.
Go Beyond Custom Media Screening And Prototyping
Learn about manufacturing solutions that streamline cell culture media scale-up with global production capabilities, equivalency strategies, and quality assurance for reliable supply.
Take The Lead With The Gibco CHOvantage™ GS Cell Line Development Kit
See how this kit accelerates clone development to 14 weeks with ≥7 g/L protein titers while reducing costs through royalty-free commercial licensing for therapeutic applications.
From Lab To Commercialization: Simplifying Bioprocess Scale-Up
Explore how unique cuboid geometries and advanced mixing dynamics create consistent performance from the bench to commercial manufacturing, ensuring flexibility and improved productivity.